Biotinylated Anti-Human I-TAC (CXCL11) 0 评论Submit a Review 产品详情 产品编号： 500-P132BT 产品描述： Source: Polyclonal Rabbit Preparation: Produced from sera of rabbits pre-immunized with highly pure (>98%) recombinant hI-TAC. Anti-Human I-TAC specific antibody was purified by affinity chromatography and then biotinylated. Immunogen: E.coli derived Recombinant Human I-TAC (CXCL11) (PeproTech catalog# 300-46) Sandwich ELISA: To detect hI-TAC by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.25 – 1.0 μg/ml of this antibody is required. This biotinylated polyclonal antibody, in conjunction with PeproTech’s Polyclonal Anti-Human I-TAC (500-P132) as a capture antibody, allows the detection of at least 0.2 – 0.4 ng/well of recombinant hI-TAC. Western Blot: To detect hI-TAC by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 µg/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant hI-TAC is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions. Note: 1mg will be provided as 2x500μg. crossreactivity: Human, Mouse, References SDS CoA 搜索 Product Line Country Of Origin: USA Not for human use. Research Interest 化学趋化 免疫系统 创伤修复 product.subtitle.recentcitations 第一作者 Vanheule, V 标题 The Positively Charged COOH-terminal Glycosaminoglycan-binding CXCL9(74-103) Peptide Inhibits CXCL8-induced Neutrophil Extravasation and Monosodium Urate Crystal-induced Gout in Mice. 文献引用 The Journal of Biological Chemistry; 290(35) pg21292-304 PubMed Id 26183778 第一作者 Loos, T 标题 Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation. 文献引用 Blood; 112(7) pg2648-56 PubMed Id 18645041 第一作者 Burke, S M 标题 Human mast cell activation with virus-associated stimuli leads to the selective chemotaxis of natural killer cells by a CXCL8-dependent mechanism. 文献引用 Blood; 111(12) pg5467-76 PubMed Id 18424663
